Advancing Transplantation Outcomes in Children
Condition:   Kidney Transplant Interventions:   Drug: Sirolimus;   Biological: Belatacept;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus (Group1);   Drug: Anti-Thymocyte Globulin (ATG);   Drug: Tacrolimus (Group 2) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Conditions:   Kidney Transplant;   Kidney Failure;   Highly Sensitized Interventions:   Drug: Cyclophosphamide;   Biological: CART-BCMA;   Biological: huCART19;   Drug: Fludarabine Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Prospective, Randomized Controlled Trial to Investigate the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
Condition:   Kidney Transplant Failure Intervention:   Other: AI-based risk prediction for kidney graft loss Sponsor:   Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.
Condition:   Infections, Cytomegalovirus Intervention:   Drug: Letermovir 240 mg Oral Tablet Sponsors:   Maimónides Biomedical Research Institute of Córdoba;   MERCK SHARP & DOHME DE ESPAÑA S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.
Conditions: Infections, Cytomegalovirus Interventions: Drug: Letermovir 240 mg Oral Tablet Sponsors: Maim ónides Biomedical Research Institute of Córdoba; MERCK SHARP& DOHME DE ESPA ÑA S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Advancing Transplantation Outcomes in Children
Conditions: Kidney Transplant Interventions: Drug: Sirolimus; Biological: Belatacept; Drug: Mycophenolate Mofetil; Drug: Tacrolimus (Group1); Drug: Anti-Thymocyte Globulin (ATG); Drug: Tacrolimus (Group 2) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Conditions: Kidney Transplant; Kidney Failure; Highly Sensitized Interventions: Drug: Cyclophosphamide; Biological: CART-BCMA; Biological: huCART19; Drug: Fludarabine Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Prospective, Randomized Controlled Trial to Investigate the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
Conditions: Kidney Transplant Failure Interventions: Other: AI-based risk prediction for kidney graft loss Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Proteinuria and Renal Perfusion in Renal Transplant Recipients
Conditions:   Pre-kidney Transplant;   Living Donor Kidney Transplantation;   Renal Perfusion;   End Stage Renal Disease Intervention:   Sponsor:   University of Erlangen-Nürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Proteinuria and Renal Perfusion in Renal Transplant Recipients
Conditions: Pre-kidney Transplant; Living Donor Kidney Transplantation; Renal Perfusion; End Stage Renal Disease Sponsors: University of Erlangen-N ürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children
Condition:   Liver Transplant; Complications Intervention:   Device: intraoperative plancement of Biliary Drainage Stent Sponsor:   Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

MYREPTIC-N ® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Condition:   Kidney Transplant Interventions:   Drug: Myreptic-N Tablet;   Drug: Mycophenolate mofetil Tablet/Capsule Sponsor:   Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials